| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13159* | 2021 |
| Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3 C Lu, F Zhu, YY Cho, F Tang, T Zykova, W Ma, AM Bode, Z Dong Molecular cell 23 (1), 121-132, 2006 | 413 | 2006 |
| Skin barrier abnormalities and immune dysfunction in atopic dermatitis G Yang, JK Seok, HC Kang, YY Cho, HS Lee, JY Lee International journal of molecular sciences 21 (8), 2867, 2020 | 290 | 2020 |
| [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase CH Jeong, AM Bode, A Pugliese, YY Cho, HG Kim, JH Shim, YJ Jeon, ... Cancer research 69 (13), 5584-5591, 2009 | 281 | 2009 |
| Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives G Battogtokh, YS Choi, DS Kang, SJ Park, MS Shim, KM Huh, YY Cho, ... Acta Pharmaceutica Sinica B 8 (6), 862-880, 2018 | 211 | 2018 |
| ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4 MO Kim, SH Kim, YY Cho, J Nadas, CH Jeong, K Yao, DJ Kim, DH Yu, ... Nature structural & molecular biology 19 (3), 283-290, 2012 | 183 | 2012 |
| Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells CH Jeong, YY Cho, MO Kim, SH Kim, EJ Cho, SY Lee, YJ Jeon, ... Stem cells 28 (12), 2141-2150, 2010 | 169 | 2010 |
| Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells AL Stratford, CJ Fry, C Desilets, AH Davies, YY Cho, Y Li, Z Dong, ... Breast Cancer Research 10, 1-12, 2008 | 169 | 2008 |
| Direct inhibition of insulin-like growth factor-I receptor kinase activity by (−)− epigallocatechin-3-gallate regulates cell transformation M Li, Z He, S Ermakova, D Zheng, F Tang, YY Cho, F Zhu, WY Ma, ... Cancer Epidemiology Biomarkers & Prevention 16 (3), 598-605, 2007 | 160 | 2007 |
| Protein tyrosine phosphatases as potential regulators of STAT3 signaling M Kim, LD Morales, IS Jang, YY Cho, DJ Kim International journal of molecular sciences 19 (9), 2708, 2018 | 159 | 2018 |
| Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1 KW Lee, NJ Kang, EA Rogozin, HG Kim, YY Cho, AM Bode, HJ Lee, ... Carcinogenesis 28 (9), 1918-1927, 2007 | 154 | 2007 |
| Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment G Battogtokh, YY Cho, JY Lee, HS Lee, HC Kang Frontiers in pharmacology 9, 922, 2018 | 128 | 2018 |
| Ribosomal S6 kinase 2 is a key regulator in tumor promoter–induced cell transformation YY Cho, K Yao, HG Kim, BS Kang, D Zheng, AM Bode, Z Dong Cancer research 67 (17), 8104-8112, 2007 | 128 | 2007 |
| Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation HS Choi, BY Choi, YY Cho, H Mizuno, BS Kang, AM Bode, Z Dong Cancer research 65 (13), 5818-5827, 2005 | 123 | 2005 |
| ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal SH Kim, MO Kim, YY Cho, K Yao, DJ Kim, CH Jeong, DH Yu, KB Bae, ... Stem cell research 13 (1), 1-11, 2014 | 120 | 2014 |
| Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase N Oi, CH Jeong, J Nadas, YY Cho, A Pugliese, AM Bode, Z Dong Cancer Research 70 (23), 9755-9764, 2010 | 120 | 2010 |
| Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR SK Jung, MH Lee, JE Kim, P Singh, SY Lee, CH Jeong, TG Lim, H Chen, ... Journal of Biological Chemistry 289 (52), 35839-35848, 2014 | 119 | 2014 |
| Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth DJ Kim, Y Li, K Reddy, MH Lee, MO Kim, YY Cho, SY Lee, JE Kim, ... Cancer research 72 (12), 3060-3068, 2012 | 112 | 2012 |
| The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development D Zheng, AM Bode, Q Zhao, YY Cho, F Zhu, WY Ma, Z Dong Cancer research 68 (10), 3992-3998, 2008 | 112 | 2008 |
| Fyn is a novel target of (−)‐epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation Z He, F Tang, S Ermakova, M Li, Q Zhao, YY Cho, WY Ma, HS Choi, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2008 | 112 | 2008 |
